Abstract

Esmolol is the first intravenous, short-acting, titratable β-blocker available for use in critical care and surgical settings [1]. Esmolol is thought to be a "jack of all trades" among drugs used in anesthesia because it prevents and treats cardiovascular responses due to perioperative stimuli.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call